Clinical trial
Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous…
NCT00191594 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00191594 |
|---|---|
| Title | Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials |
| Official title | Open-Label Duloxetine Extension Phase in Patients Who Have Completed the HMDG Clinical Trial |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine Hydrochloride |
| Enrollment | 105 |
| Start date | Mar 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 26, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: